About this trial
The present study, OBPM\_COYOTE2024, with N = 255 participants minimum over 1 visit (lasting \~15min), has been designed to collect raw optical data with Aktiia.product-G2C Clinical investigational device together with Aktiia G2 Bracelet and Aktiia Init I1 oscillometric cuff within a cohort of subjects characterized by a wide variety of phenotypes. The resulting dataset will support research and development activities conducted by AKTIIA SA out of the study context.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Subjects aged 21 to 85yo
Subjects or witnesses fluent in written and spoken French
Subjects agreeing to attend the study visit and follow study procedures
Subjects that have signed the informed consent form.
Disqualifiers
Amputated index fingers
Damaged/injured skin at index fingers
Damaged/injured skin at wrists
Subjects with tachycardia (heart rate at rest > 120bpm)
Trial design
Single group
Treatments tested in this trial
Aktiia G2C
DeviceStudy subjects are asked to stay seated while 3 successive measurements are taken with the Aktiia G2C device under investigation (BP and PR) and two references (Aktiia Bracelet G2 and Aktiia Init I1 oscillometric cuff).
Treatment groups
Trial outcomes
Primary outcomes
Data set build
Number of subjects including three assessments of blood pressure using Aktiia G2C Clinical, alongside three assessments of blood pressure with Aktiia Bracelet G2 and three values of blood pressure generated with the Aktiia Init I1 oscillometric cuff